Parp Inhibition

How PARP inhibitors (PARPi) work

PARP Inhibitors

Choosing the correct PARP inhibitor for prostate cancer

Overcoming resistance to PARP inhibition in ovarian cancer

Mechanisms of PARP Inhibition: A Mode of Targeted Cancer Treatment

Updates in PARP inhibition for ovarian cancer

Gynecologic Cancer Education: PARP Inhibitor Therapy

PARP Inhibitors for Prostate Cancer

Cleveland Clinic

Seminar Clips: PARP Inhibitors and BRRCA1/2 Cancers- Susan Domchek, MD | Stanford Cancer Institute

Stanford Cancer Institute

An Overview of PARP Inhibitors in Ovarian Cancer

Targeted Oncology

PARP Inhibitors for Maintenance Therapy in Ovarian Cancer

Cleveland Clinic

PARP inhibitors – a cancer drug discovery story | Professor Ruth Plummer FMedSci

PARP inhibitors for ovarian cancer

PARP Inhibition Improves Outcomes in Patients With BRCA-Mutated Ovarian Cancer

Targeted Oncology

The benefits of adjuvant CDK4/6 and PARP inhibition in breast cancer

Dr. Richards on PARP Inhibition in Pancreatic Cancer

The Role of Targeting DNA Repair with PARP

Grand Rounds in Urology

Do I Need PARP Inhibitors To Treat My Breast Cancer? What to Expect, Eligibility, and Side Effects

Yerbba – Breast Cancer

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat

Assessing PARP inhibition and BRCA1/2 as a prognostic biomarker in mCRPC